• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET Back to Search Results
Model Number 10220
Device Problem Insufficient Information (3190)
Patient Problem Fever (1858)
Event Date 12/31/2019
Event Type  Injury  
Manufacturer Narrative
Lot number and expiry are not available at this time.Article citation: johann, pascal d., et.Al.2022.Identifying patient groups that may benefit from granulocyte transfusions in pediatric hematology and oncology.Journal of pediatric hematology/oncology.44:7, e968¿e975.Investigation is in process.A follow up report will be provided.
 
Event Description
The journal article, 'identifying patient groups that may benefit from granulocyte transfusions in pediatric hematology and oncology' describes a retrospective review of patients treated with granulocyte transfusions from 2004 to 2019, median age 3 years, age range 1 to 10 years.In 99 granulocyte transfusions, the chart review identified 2 possibly related adverse events: patients 7 reacted with fever during the transfusion.In this case, this was not clearly attributable to the granulocyte infusion but could also have developed in the context of the ongoing infection.Of 10 patients who received allogeneic stem cell transplantation and survived until at least 28 days after transplantation, none experienced graft rejection and 1 suffered from acute and chronic gvhd.The article does not specify if medical intervention was required.The article does not provide further patient information details.The collection sets are not available for return for evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA EXCHANGE SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer (Section G)
TERUMO BCT
10810 w. collins ave
lakewood CO 80215
Manufacturer Contact
scot hilden
10810 w. collins ave
lakewood, CO 80215
MDR Report Key16496101
MDR Text Key310801540
Report Number1722028-2023-00096
Device Sequence Number1
Product Code GKT
UDI-Device Identifier05020583102200
UDI-Public05020583102200
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
BK150251
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 03/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number10220
Device Catalogue Number10220
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/10/2023
Initial Date FDA Received03/07/2023
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-